-
-5%
Plinart Syringe Pre-Filled Intra-Articular Gel 2ml
54.15€
57.00€
- Brand: MASTELLI Srl
- Product Code: 935679365
- EAN:
- Availability: In 10 - 14 Days
- Purchase 3 items for 53.07€ each
- Purchase 4 items for 51.98€ each
- Purchase 5 items for 50.90€ each
Plinart
Pre-Filled Gel Syringe
Intra-articular gel with Polynucleotides
Polynucleotide gel, lubricant and viscosifier of the joints.
STERILE - APYROGEN - DISPOSABLE
Packaging
Carton containing a pre-filled, sterile, non-pyrogenic glass syringe.
Each syringe contains 2.0 ml of solution.
Composition
Each pre-filled syringe contains: 20 mg / ml polynucleotides, water for injectable preparations, sodium chloride, monobasic sodium phosphate dihydrate, dibasic sodium phosphate dihydrate.
Product description
Plinart is a viscoelastic, transparent, colorless solution based on polynucleotides; it comes in the form of a pre-filled, sterile, non-pyrogenic, disposable glass syringe containing 2.0 ml of solution.
The polynucleotides are highly purified, of fish origin and have a concentration of 20 mg / ml
Plinart is characterized by viscoelasticity and by a high power to dissolve numerous water molecules, therefore it allows to lubricate and promote the normalization of the viscosity of the synovial fluid.
Indications
Painful joint pathologies attributable to degenerative, post-traumatic diseases or joint alterations.
Plinart thanks to its viscoelastic and lubricating properties favors the restoration of the rheological and physiological conditions of the joints.
Plinart, by improving the characteristics of the synovial fluid, exerts a protective action on the joints and promotes the physiological repair mechanisms at the level of the articular cartilage.
These properties contribute both to the improvement of joint function and to the reduction of painful symptoms.
How to use
Plinart is injected into the joint cavity using a 20 G needle
The intra-articular infiltration must be performed by expert medical personnel, observing the technical and aseptic rules prescribed for this mode of administration.
Given the viscosity of the solution, to ensure a shaft seal and prevent the product from leaking between the needle and syringe during administration, screw the needle firmly to the Luer-type locking collar of the syringe.
Dosage
As a guide, unless otherwise advised by a doctor, infiltrate 2.0 ml of product (40 mg dipolinucleotides) intra-articularly once a week for 3-6 weeks.
Limitations of use
The use of Plinart is contraindicated in subjects with hypersensitivity to the components of the product or with a positive history of allergy to products of ictic origin.
Plinart should not be injected in the presence of an infected or severely inflamed joint or if the patient has an infection near the site to be infiltrated, to avoid the possibility of bacterial arthritis.
The safety efficacy of Plinart has not been established in pregnant or lactating women and children.
Side effects
Adverse events associated with the practice of intra-articular injections are possible with Plinart such as: pain, sensation of heat, redness or swelling.
These secondary manifestations can be contained by keeping the joint at rest and applying ice locally.
They usually disappear after a short time. If symptoms persist, seek medical attention.
The physician should ensure that patients inform him of any side effects that may occur after treatment.
Precautions for use
Plinart is designed for single use only.
Plinart should be used with particular care in the presence of lymphatic or venous stasis in the leg to be treated.
In the presence of joint effusion, aspiration is recommended before injecting the product.
After the intra-articular injection, it is recommended that the patient avoid physical activities that are demanding on the joint and resume normal activities after a couple of days.
Do not use disinfectants based on quaternary ammonium salts or chlorhexidine.
Do not inject vascularly, outside the joint cavity, into the synovial tissue or into the joint capsule.
Do not inject if you notice impurities in the syringe.
Warnings
Keep out of reach of children.
The injection i
ntra-articular can only be performed by medical personnel. Check the integrity of the syringe packaging before use: do not use Plianrt if the packaging is already open or damaged.
Do not use after the expiry date indicated on the carton.
The expiry date refers to the intact product, correctly stored.
Keep the container tightly closed, away from light and heat.
Do not freeze.
Once opened, Plinart must be used immediately and discarded after use.
Do not disperse in the environment after use.
Carton containing a pre-filled, sterile, non-pyrogenic glass syringe.
Each syringe contains 2.0 ml of solution.
Composition
Each pre-filled syringe contains: 20 mg / ml polynucleotides, water for injectable preparations, sodium chloride, monobasic sodium phosphate dihydrate, dibasic sodium phosphate dihydrate.
Product description
Plinart is a viscoelastic, transparent, colorless solution based on polynucleotides; it comes in the form of a pre-filled, sterile, non-pyrogenic, disposable glass syringe containing 2.0 ml of solution.
The polynucleotides are highly purified, of fish origin and have a concentration of 20 mg / ml
Plinart is characterized by viscoelasticity and by a high power to dissolve numerous water molecules, therefore it allows to lubricate and promote the normalization of the viscosity of the synovial fluid.
Indications
Painful joint pathologies attributable to degenerative, post-traumatic diseases or joint alterations.
Plinart thanks to its viscoelastic and lubricating properties favors the restoration of the rheological and physiological conditions of the joints.
Plinart, by improving the characteristics of the synovial fluid, exerts a protective action on the joints and promotes the physiological repair mechanisms at the level of the articular cartilage.
These properties contribute both to the improvement of joint function and to the reduction of painful symptoms.
How to use
Plinart is injected into the joint cavity using a 20 G needle
The intra-articular infiltration must be performed by expert medical personnel, observing the technical and aseptic rules prescribed for this mode of administration.
Given the viscosity of the solution, to ensure a shaft seal and prevent the product from leaking between the needle and syringe during administration, screw the needle firmly to the Luer-type locking collar of the syringe.
Dosage
As a guide, unless otherwise advised by a doctor, infiltrate 2.0 ml of product (40 mg dipolinucleotides) intra-articularly once a week for 3-6 weeks.
Limitations of use
The use of Plinart is contraindicated in subjects with hypersensitivity to the components of the product or with a positive history of allergy to products of ictic origin.
Plinart should not be injected in the presence of an infected or severely inflamed joint or if the patient has an infection near the site to be infiltrated, to avoid the possibility of bacterial arthritis.
The safety efficacy of Plinart has not been established in pregnant or lactating women and children.
Side effects
Adverse events associated with the practice of intra-articular injections are possible with Plinart such as: pain, sensation of heat, redness or swelling.
These secondary manifestations can be contained by keeping the joint at rest and applying ice locally.
They usually disappear after a short time. If symptoms persist, seek medical attention.
The physician should ensure that patients inform him of any side effects that may occur after treatment.
Precautions for use
Plinart is designed for single use only.
Plinart should be used with particular care in the presence of lymphatic or venous stasis in the leg to be treated.
In the presence of joint effusion, aspiration is recommended before injecting the product.
After the intra-articular injection, it is recommended that the patient avoid physical activities that are demanding on the joint and resume normal activities after a couple of days.
Do not use disinfectants based on quaternary ammonium salts or chlorhexidine.
Do not inject vascularly, outside the joint cavity, into the synovial tissue or into the joint capsule.
Do not inject if you notice impurities in the syringe.
Warnings
Keep out of reach of children.
The injection i
ntra-articular can only be performed by medical personnel. Check the integrity of the syringe packaging before use: do not use Plianrt if the packaging is already open or damaged.
Do not use after the expiry date indicated on the carton.
The expiry date refers to the intact product, correctly stored.
Keep the container tightly closed, away from light and heat.
Do not freeze.
Once opened, Plinart must be used immediately and discarded after use.
Do not disperse in the environment after use.